IP Library Granted Patent US 7,786,160
Granted Patent B2
US 7,786,160 · App. 11/133,190 · Granted Aug 31, 2010

Combination of selected analgesics and COX-II inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,786,160
App. No.
11/133,190
Granted
Aug 31, 2010
Kind
B2
Abstract

Combinations of certain analgesics with certain COX-II inhibitors, related pharmaceutical compositions, including advantageous galenical forms containing these combinations, and to the use thereof in methods of treatment, in particular for the treatment of pain.

Claims (18)

1. An active ingredient combination comprising synergistically effective amounts of at least one analgesic compound A and at least one COX-II inhibitor,

where compound A is selected from the group consisting of:

(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol; and

(1S,2S)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol;

or a salt thereof with a physiologically tolerated acid, and

where the COX-II inhibitor is selected from the group consisting of:

celecoxib; and

rofecoxib.

2. The active ingredient combination of claim 1 , wherein compound A is present in the form of a hydrochloride.

3. The active ingredient combination of claim 1 , wherein compound A is present in the form of a base.

4. The active ingredient combination of claim 1 , wherein compound A is present in the form of a pure enantiomer or pure diastereoisomer.

5. The active ingredient combination of claim 1 , wherein compound A is present in the form of a mixture of stereoisomers.

6. The active ingredient combination of claim 1 , wherein compound A is present in the form of a racemic mixture.

7. A pharmaceutical formulation comprising an active ingredient combination according to claim 1 and a suitable auxiliary substance.

8. The pharmaceutical formulation of claim 7 , further comprising at least one other active ingredient.

9. A method of alleviating pain in a mammal, said method comprising administering to said mammal an effective pain alleviating amount of an active ingredient combination according to claim 1 .

10. The method of claim 9 wherein said pain is neuropathic, acute, chronic, visceral or cancer pain.

11. The method of claim 9 , wherein said pain is inflammatory pain.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF RECEIVING PARTY IN RELEASE OF PATENT SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS PREVIOUSLY RECORDED ON REEL 032380 FRAME 0157. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS.. Recorded Mar 24, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 032513/0255 →
GRANT OF SECURITY INTEREST IN LICENSED PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0620 →
RELEASE OF PATENT SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0157 →
RELEASE OF SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS RECORDED AT REEL/FRAME 25456/172 Recorded Jul 12, 2011
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 026577/0357 →
SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS Recorded Jul 8, 2011
From: ENDO PHARMACEUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026561/0978 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS (EXCLUSIVELY LICENSED PATENTS) Recorded Dec 9, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025456/0172 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 23928/628 Recorded Dec 9, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 025456/0778 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS (EXCLUSIVELY LICENSED PATENTS) Recorded Feb 13, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023928/0628 →
LICENSE Recorded Oct 30, 2009
From: GRUNENTHAL GMBH
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 023449/0279 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2005
From: SCHIENE, KLAUS; HAASE, GUENTER; KOEGEL, BABETTE-YVONNE; FRIDERICHS, ELMAR; JAHNEL, ULRICH
To: GRUENENTHAL GMBH
Reel/Frame 016920/0697 →